|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||
|
|||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Human Signaling lymphocytic activation molecule (aa 21-335) |
| SLAM Swiss Prot# | | Q13291 |
| SLAM Protein names | | Signaling lymphocytic activation molecule (IPO-3) (CDw150) (CD antigen CD150) |
| SLAM Gene names | | SLAMF1 (SLAM) |
| Organism | | Human |
| SLAM Entry name | | SLAF1_HUMAN |
| SLAM Codon optimized cDNA(gene) Clone |
| SLAM Cat # | | RPT0169 |
| Tag | | SLAM contains A 6x histidine tag |
| SLAM Formulation | | Liquid |
| SLAM Storage | | Storage at -20℃ to −80℃ Upon receipt. Avoid repeated freeze-thaw cycles. |
| SLAM Applications | | Applications: 1. Codon-optimized cDNA(gene) sequence designed for protein production in both E.coli and Mammalian cell. The cDNA(gene) has been cloned into E.coli expression vector with 6x Histidine tag.2. May be used as RNAi assistance to restore the loss-of-function. |
| Recombinant SLAM Protein |
| SLAM Cat # | | PT0169 |
| SLAM Source | | recombinant |
| SLAM Applications | | Western Blot, SDS-Page or may be used for other applications determined by user |
| SLAM Purity | | >90%, as determined by SDS-PAGE under reducing conditions |
| SLAM Activity | | N/A |
| Tag | | SLAM Contains A 6x histidine tag |
| SLAM Formulation | | Liquid |
| SLAM Storage | | ;. Storage at -20℃ to −80℃ Upon receipt. Avoid repeated freeze-thaw cycles. |
| Place Order for Recombinant SLAM Products | | For pricing and availability Click Here >>> |
| SLAM family | | - |
| SLAM Subcellular locations | | Cell membrane; Single-pass type I membrane protein. |
| SLAM FUNCTION According to UniProtKB Swiss Prot | | FUNCTION: High-affinity self-ligand important in bidirectional T-cell to B-cell stimulation. SLAM-induced signal-transduction events in T-lymphocytes are different from those in B-cells. Two modes of SLAM signaling are likely to exist: one in which the inhibitor SH2D1A acts as a negative regulator and another in which protein-tyrosine phosphatase 2C (PTPN11)-dependent signal transduction operates. |
| SLAM Sequence | | DDBJ | EMBL | GenBank |
| SLAM 3D structure | | ModBase |
| SLAM interaction | | STRING |
| SLAM Proteomic | | PRIDE |
| SLAM Proteomic | | Ensembl | GeneID | KEGG | UCSC |
| SLAM Organism specific | | CTD | MGI |
| SLAM Phylogenomics | | eggNOG | GeneTree | HOGENOM | HOVERGEN |
| | InParanoid | OrthoDB | PhylomeDB | OMA |
| SLAM Gene expression | | Bgee | ArrayExpress | Genevestigator |
| SLAM Family and domain | | InterPro | PROSITE | ProtoNet |
| FOR in vitro RESEARCH USE ONLY |